Europe Lab-on-a-chip And Microarrays Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

1. INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
  • 4.2.2 Increasing Demand for Point-of-Care-Testing
  • 4.2.3 Increasing Applications of Proteomics and Genomics in Cancer Research
• 4.3 Market Restraints
  • 4.3.1 Design Constraints of Lab-on-chip Technology
  • 4.3.2 Availability of Alternative Technologies
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

• 5.1 By Type
  • 5.1.1 Lab-on-a-Chip
  • 5.1.2 Microarray
• 5.2 By Products
  • 5.2.1 Instruments
  • 5.2.2 Reagents & Consumables
  • 5.2.3 Software and Services
• 5.3 By Application
  • 5.3.1 Clinical Diagnostics
  • 5.3.2 Drugs Discovery
  • 5.3.3 Genomics and Proteomics
  • 5.3.4 Others
• 5.4 By End-User
  • 5.4.1 Biotechnology & Pharmaceutical Companies
  • 5.4.2 Hospitals & Diagnostics Centres
  • 5.4.3 Academic & Research Institute
• 5.5 By Country
  • 5.5.1 Germany
  • 5.5.2 United Kingdom
  • 5.5.3 France
  • 5.5.4 Italy
  • 5.5.5 Spain
  • 5.5.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abbott Laboratories
  • 6.1.2 Agilent Technologies
  • 6.1.3 Bio-Rad Laboratories
  • 6.1.4 Perkin Elmer Inc.
  • 6.1.5 GE Healthcare
  • 6.1.6 ThermoFisher Scientific
  • 6.1.7 F. Hoffmann-La Roche Ltd
  • 6.1.8 BioMerieux
  • 6.1.9 Illumina Inc.
• *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS